Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin biomarker study in primary breast cancer
2007-000306-70Phase 4Completed
- Sponsor
- University of Dundee
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of metformin in breast cancer, sponsored by University of Dundee. Primary endpoints: Biomarker activity in the LKB1/AMPK/mTOR network, Breast cancer cell proliferation and 1 more. Started Apr 2007; status: completed.
02
Drugs
metformin
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2007-000306-70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000306-70.